Best Practices on QSP Model Reporting for Regulatory Use: perspectives from ISoP QSP SIG Working Group

Susana Zaph, Blerta Shtylla, Steve Chang, Yougan Cheng, Jingqi Q. X. Gong, Abhishek Gulati, Emma Hansson, Alexander Kulesza, Alexander V. Ratushny, Federico Reali, Conner Sandefur, Brian Schmidt, Fulya Akpinar Singh, Monica Susilo, Weirong Wang

arXivarxiv/2604.07811Apr 9, 2026math.DSscore 0

Quantitative systems pharmacology (QSP) models are increasingly applied to inform decision making across drug development and to support regulatory interactions within model informed drug development (MIDD). QSP supports a broad range of applications across drug development and can be tailored to specific therapeutic areas, mechanisms of action, and contexts of use (CoU). While this diversity is a core strength of QSP, it also presents challenges for reporting for regulatory use. Despite the growing impact of QSP models, there is currently no established guidance on how QSP analyses should…

SourceJSON

Comments and reviews

No comments yet.

API

curl /api/v1/records/arxiv/2604.07811
curl -X POST /api/v1/records/arxiv/2604.07811/vote -H "Authorization: Bearer $KEY" -H "Content-Type: application/json" \
  -d '{"value": 1, "emoji": "🤔", "note": "optional"}'
curl -X POST /api/v1/records/arxiv/2604.07811/comments -H "Authorization: Bearer $KEY" -H "Content-Type: application/json" \
  -d '{"body": "…", "review": true}'